ImmunityBio Holds Golden Cross As Stock Trades 170% Above 200-Day Average

Benzinga_recent_news02-20

ImmunityBio Inc (NASDAQ:IBRX) stock is maintaining a confirmed Golden Cross, with the stock now trading roughly 170% above its 200-day moving average — a measurable signal of sustained long-term trend...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2612328134?lang=en_US&edition=fundamental","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/02/19/San-Diego--Ca--Usa---July-9--2022-Immuni.jpeg?optimize=medium&dpr=2&auto=webp&width=240","is_english":true,"pubTime":"2026-02-20 00:37","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2612328134","market":"us","top_or_hot":-1,"title":"ImmunityBio Holds Golden Cross As Stock Trades 170% Above 200-Day Average","media":"Benzinga_recent_news","content":"<div>\n<p>ImmunityBio Inc (NASDAQ:IBRX) stock is maintaining a confirmed Golden Cross, with the stock now trading roughly 170% above its 200-day moving average — a measurable signal of sustained long-term trend...</p>\n\n<a href=\"https://www.benzinga.com/trading-ideas/technicals/26/02/50725805/immunitybio-holds-golden-cross-as-stock-trades-170-above-200-day-average\">Source Link</a>\n\n</div>\n","source":"benzinga_recent_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ImmunityBio Holds Golden Cross As Stock Trades 170% Above 200-Day Average</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nImmunityBio Holds Golden Cross As Stock Trades 170% Above 200-Day Average\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-02-20 00:37 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/trading-ideas/technicals/26/02/50725805/immunitybio-holds-golden-cross-as-stock-trades-170-above-200-day-average><strong>Benzinga_recent_news</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>ImmunityBio Inc (NASDAQ:IBRX) stock is maintaining a confirmed Golden Cross, with the stock now trading roughly 170% above its 200-day moving average — a measurable signal of sustained long-term trend...</p>\n\n<a href=\"https://www.benzinga.com/trading-ideas/technicals/26/02/50725805/immunitybio-holds-golden-cross-as-stock-trades-170-above-200-day-average\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IBRX","symbol_name":"ImmunityBio, Inc.","start_time":0,"source_url":"https://www.benzinga.com/trading-ideas/technicals/26/02/50725805/immunitybio-holds-golden-cross-as-stock-trades-170-above-200-day-average","article_id":"2612328134","we_media_id":null,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/02/19/San-Diego--Ca--Usa---July-9--2022-Immuni.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/trading-ideas/technicals/26/02/50725805/immunitybio-holds-golden-cross-as-stock-trades-170-above-200-day-average","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2612328134","pubTimestamp":1771519020,"columns":[],"sourceInfo":{"source_id":"benzinga_recent_news","name":"Benzinga"},"weMediaInfo":null,"summary":"ImmunityBio holds a Golden Cross as the stock trades 170% above its 200-day average, with elevated trading volume supporting the trend.","collect":0,"end_time":0,"defaultTopTitle":"benzinga.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"IBRX":"ImmunityBio, Inc.","BK4139":"生物科技","RSI":"Rush Street Interactive, Inc.","BK4150":"赌场与赌博"},"translate_title":"ImmunityBio持有Golden Cross，股价较200日平均水平高出170%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RSI":1,"IBRX":1},"content_text":"ImmunityBio Inc (NASDAQ:IBRX) stock is maintaining a confirmed Golden Cross, with the stock now trading roughly 170% above its 200-day moving average — a measurable signal of sustained long-term trend strength.\nIBRX stock is currently trading near $8.04, while the 200-day moving average sits at approximately $2.95. The Golden Cross was established after the 50-day moving average rose above the 200-day moving average, and the widening gap between the two continues to reflect a strong upward trend.\nIBRX stock is now trading above all major moving averages, confirming alignment across short-, medium-, and long-term trend indicators. The stock is about 24% above its 20-day moving average of $6.90 and roughly 91% above its 50-day moving average of $4.21.\nTrading above these levels indicates sustained price strength over multiple timeframes. The 200-day moving average, in particular, serves as a widely followed indicator of long-term trend direction. Stocks holding significantly above this level are generally considered to be in established uptrends.\nImmunityBio's average daily trading volume has risen to approximately 1.7 million shares based on its 9-day volume average, reflecting increased market participation compared to earlier periods.\nMomentum indicators also remain elevated. The Relative Strength Index (RSI) is currently near 67, indicating strong upward momentum while remaining below the overbought threshold of 70. This suggests sustained buying pressure without reaching extreme levels historically associated with short-term exhaustion.\nThe 50-day moving average currently stands at $4.21, approximately 42% above the 200-day moving average. This confirms the persistence of the Golden Cross structure, which occurs when shorter-term price trends exceed long-term averages.\nWith price holding well above the 200-day level and momentum indicators remaining strong, ImmunityBio continues to maintain a technically confirmed long-term uptrend.\nImage: Shutterstock\nTo add Benzinga News as your preferred source on Google, click here.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2612328134","isCrawlerRequest":true}